Pea F.; Scudeller L.; Lugano M.; Baccarani U.; Pavan F.; Tavio M.; Furlanut M.; Della Rocca G.; Bresadola F.; Viale P., Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient [4], «CLINICAL INFECTIOUS DISEASES», 2006, 42, pp. 434 - 435 [Comment or similar]
Pea F.; Pavan F.; Lugatti E.; Dolcet F.; Talmassons G.; Screm M.C.; Furlanut M., Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis, «CLINICAL PHARMACOKINETICS», 2006, 45, pp. 287 - 295 [Scientific article]
Pea F.; Furlanut M.; Stellini R.; Bonardelli S.; Signorini L.; Pavan F.; Matheis A.; Portolani N.; Lorenzotti S.; Giulini S.M.; Viale P.; Carosi G., Pharmacokinetic-pharmacodynamic aspects of antimicrobial prophylaxis with teicoplanin in patients undergoing major vascular surgery, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2006, 27, pp. 15 - 19 [Scientific article]
Pea F.; Viale P., The antimicrobial therapy puzzle: Could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?, «CLINICAL INFECTIOUS DISEASES», 2006, 42, pp. 1764 - 1771 [Scientific article]
Pea F.; Viale P.; Pavan F.; Tavio M.; Poz D.; Beltrame A.; Furlanut M., The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2006, 27, pp. 344 - 350 [Scientific article]
Pasticci M.B.; Altissimi M.; Azzara A.; Di Candilo F.; Lapalorcia L.M.; Giustelli G.; Pea F.; Baldelli F., Treatment of post-traumatic hand Staphylococcus aureus osteomyelitis with oral linezolid, «JOURNAL OF CHEMOTHERAPY», 2006, 18, pp. 425 - 429 [Scientific article]
Pea F.; Poz D.; Viale P.; Pavan F.; Furlanut M., Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2006, 58, pp. 380 - 386 [Scientific article]
Pea F.; Viale P.; Furlanut M., Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability, «CLINICAL PHARMACOKINETICS», 2005, 44, pp. 1009 - 1034 [Scientific article]
Pea F.; Viale P.; Damiani D.; Pavan F.; Cristini F.; Fanin R.; Furlanut M., Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: Helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2005, 49, pp. 3550 - 3553 [Scientific article]
Pea F; Mazzei T, Farmaci antifungini, in: Farmacologia – Principi di base e applicazioni terapeutiche, Milano, Edizioni Minerva Medica, 2005, pp. 644 - 652 [Legal Commentary]
Furlanut M; Pea F, Farmacocinetica–, in: Farmacologia - Principi di base e applicazioni terapeutiche, Milano, Edizioni Minerva Medica, 2005, pp. 7 - 17 [Legal Commentary]
Pea, F, Pharmacology of drugs for hyperuricemia. Mechanisms, kinetics and interactions, «CONTRIBUTIONS TO NEPHROLOGY», 2005, 147, pp. 35 - 46 [Scientific article]
Pea F.; Furlanut M., Levofloxacin PK/PD: From sequential therapy model to high dosage for critical patients, «JOURNAL OF CHEMOTHERAPY», 2004, 16, pp. 8 - 10 [Scientific article]
Pea F.; Viale P.; Lugano M.; Pavan F.; Scudeller L.; Rocca G.D.; Furlanut M., Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: A report of 2 cases, «AMERICAN JOURNAL OF KIDNEY DISEASES», 2004, 44, pp. 1097 - 1102 [Comment or similar]
Pea F.; Viale P.; Candoni A.; Pavan F.; Pagani L.; Damiani D.; Casini M.; Furlanut M., Teicoplanin in patients with acute leukaemia and febrile neutropenia: A special population benefiting from higher dosages, «CLINICAL PHARMACOKINETICS», 2004, 43, pp. 405 - 415 [Scientific article]
